Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

Conditions:   Hyperphosphatemia;   End Stage Renal Disease;   ESRD Interventions:   Drug: Ferric Citrate;   Drug: Sevelamer Carbonate Sponsors:   Panion & BF Biotech Inc.;   Shandong Weigao Panion Pharmaceutical Co. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials